Strength
600; 50; 300 mg/1; mg/1; mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702023113
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINEApproval Type
New Drug (NDA)
FDA Application
NDA205551On Market Since
8/22/2014
Pharmacological Classes
Cytochrome P450 1A1 Inhibitors
HIV Integrase Inhibitors
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Multidrug and Toxin Extrusion Transporter 1 Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Organic Cation Transporter 2 Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
EPIVIR 10 MG/ML ORAL SOLN
Brand
49702020548•ViiV Healthcare Company
$0.4452
per ML
ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
EPIVIR 150 MG TABLET
Brand
49702020318•ViiV Healthcare Company
$6.6144
per EA
LAMICTAL 25 MG TABLET
Brand
00173063302•GlaxoSmithKline LLC
$10.2773
per EA
LAMICTAL 100 MG TABLET
Brand
00173064255•GlaxoSmithKline LLC
$10.9197
per EA
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
LAMICTAL 25 MG DISPER TABLET
Brand
00173052700•GlaxoSmithKline LLC
$11.2131
per EA
LAMICTAL 150 MG TABLET
Brand
00173064360•GlaxoSmithKline LLC
$11.4710
per EA
LAMICTAL 200 MG TABLET
Brand
00173064460•GlaxoSmithKline LLC
$12.0609
per EA
LAMICTAL ODT 25 MG TABLET
Brand
00173077202•GlaxoSmithKline LLC
$12.8016
per EA